AT-9010 is primarily used in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor of certain kinases that are involved in the growth and proliferation of cancer cells. Researchers utilize AT-9010 to investigate its effects on tumor suppression and to explore its potential as a targeted treatment for various types of cancers. Its application extends to preclinical studies where it helps in understanding the molecular pathways that drive cancer progression, thereby aiding in the development of novel therapeutic strategies. Additionally, AT-9010 is employed in pharmacological studies to assess its efficacy, safety, and pharmacokinetic properties, which are crucial for determining its suitability for clinical trials.